Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences; Business Will Be Called Cytiva
March 31 2020 - 6:00PM
PR Newswire (US)
WASHINGTON, March 31, 2020 /PRNewswire/ -- Danaher
Corporation (NYSE: DHR) ("Danaher") announced today the completion
of its acquisition of the Biopharma business from General Electric
Company's (NYSE: GE) Life Sciences division. As part of Danaher,
the business will be called Cytiva and will be a standalone
operating company within Danaher's Life Sciences segment.
ABOUT DANAHER
Danaher is a global science and
technology innovator committed to helping its customers solve
complex challenges and improving quality of life around the world.
Its family of world class brands has leadership positions in the
demanding and attractive health care, environmental and applied
end-markets. With more than 20 operating companies, Danaher's
globally diverse team of approximately 67,000 associates is united
by a common culture and operating system, the Danaher Business
System, and its Shared Purpose, Helping Realize Life's
Potential. For more information, please visit
www.danaher.com.
View original
content:http://www.prnewswire.com/news-releases/danaher-completes-acquisition-of-the-biopharma-business-of-general-electric-life-sciences-business-will-be-called-cytiva-301032965.html
SOURCE Danaher Corporation
Copyright 2020 PR Newswire
Danaher (NYSE:DHR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Danaher (NYSE:DHR)
Historical Stock Chart
From Apr 2023 to Apr 2024